Prev: mebendazole, approved generic drug, active against chemo-resistant metastatic melanoma
Next: STUDY: A Critical Review of Perioperative Complications in 175 Free Deep Inferior Epigastric Perforator Flap Breast Reconstructions.
From: Ilena Rose on 11 Aug 2008 01:42
http://breastimplantawareness.blogspot.com

Outcome Following Removal of Infected Tissue Expanders in Breast
Reconstruction: A 10-Year Experience.

http://www.annalsplasticsurgery.com/pt/re/annps/currenttoc.htm;jsessionid=G3Fb879RgH3qsLy6TyyJQTKp155hWFCF7RK4XWnFKXjPyklZCPzv!2112021004!181195629!8091!-1

Eric G. Halvorson, MD; Joseph J. Disa, MD; Babak J. Mehrara, MD;
Brooke A. Burkey, MD; Andrea L. Pusic, MD; Peter G. Cordeiro, MD

Of 39 tissue-expander breast reconstructions requiring premature
removal of the expander for infection, 31% had undergone prior
radiation. Although 67% did not undergo secondary reconstruction,
those who were unirradiated were able to elect to repeat the
procedure.
 | 
Pages: 1
Prev: mebendazole, approved generic drug, active against chemo-resistant metastatic melanoma
Next: STUDY: A Critical Review of Perioperative Complications in 175 Free Deep Inferior Epigastric Perforator Flap Breast Reconstructions.